Staying in a Tighter Blood Sugar Range May Help Protect the Retina, Study Suggests

Researchers looked at how closely adults with Type 1 diabetes kept their blood glucose within two different target ranges. Time in Range (TIR), the standard used in many diabetes care programs, aims for 70–180 mg/dL. Time in Tight Range (TITR) is much narrower: 70–140 mg/dL, which is closer to what a non-diabetic body naturally maintains.

Using continuous glucose monitors (CGMs), the team tracked over 250,000 individual glucose readings from 153 hospitalized adults with Type 1 diabetes. They also used advanced eye imaging called optical coherence tomography angiography (OCTA) to examine the smallest blood vessels in the back of the eye—the retina—and looked for signs of diabetic retinopathy (damage to these vessels from high blood sugar over time).

The data revealed a clear connection: for every 10 percentage points higher someone's TITR score was, their odds of having diabetic retinopathy dropped by 29%. This association held steady across different glucose levels—there was no threshold beyond which the benefit leveled off.

When researchers compared TITR to the standard TIR measure, both showed benefits for blood vessel health in the retina. However, TITR was more closely tied to specific improvements in the deeper layers of retinal blood vessels, especially at the 50% cutoff point. The standard TIR measure, even at its typical 70% target, did not show the same consistent improvements.

These findings add to growing evidence that the tighter your blood sugar control, the better the long-term protection for small blood vessels—in this case, in the eye. Since diabetic retinopathy is a leading cause of vision loss in working-age adults, understanding factors that reduce its risk matters.

It's important to note that maintaining Time in Tight Range is more challenging than standard time-in-range targets and requires careful glucose monitoring and management. The study also found that people spending more time in TITR had fewer hypoglycemic (low blood sugar) episodes, though anyone aiming for tighter control should do so under medical supervision and with a clear plan for managing low blood sugar safely.

The research was conducted in a hospitalized setting with people using continuous glucose monitors and advanced technology, so results may not directly apply to all people with Type 1 diabetes or those using older monitoring methods. More research in broader populations is needed to confirm these findings and determine how best to achieve and sustain tight glucose control while keeping people safe.

Source: Endocrine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.